NC9

Overview

NC9 (Cbz-Lys(Acr)-PEG2-dansyl) is an irreversible transglutaminase ( TG ) inhibitor. NC9 inhibits osteoblast differentiation and mineralization. NC9 destabilizes microtubules. NC9 can be used for the research of osteoblast differentiation.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Others | Products > Signaling Pathways > Glutaminase | Products > Signaling Pathways > Microtubule/Tubulin

Product Information

• Catalog No.: HY-129126
• CAS No.: 1352090-52-8
• Molecular Formula: C35H47N5O8S
• Molecular Weight: 697.84
• Purity: 99.98%
• Storage: -20°C, protect from light, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)
• Solubility: ≥ 2.5 mg/mL (3.58 mM); Clear solution
• Availability: In-stock

Source

Original product source